Skip to main content
. 2019 Jan 16;20(2):360. doi: 10.3390/ijms20020360

Figure 4.

Figure 4

Triptolide inhibits ERK1/2 and JNK activation in cardiac fibroblasts. The cells were treated as described in Figure 2 and analyzed by Western blot with antibodies against (A) JNK and p-JNK, (B) ERK1/2 and p-ERK1/2, (C) p38 and p-p38, and (D) MyD88. Histograms represent the protein ratio, normalized to total JNK, total ERK, total p38, or GAPDH (n = 3), respectively. * p < 0.01 vs. medium; # p < 0.01 vs. AngII.

HHS Vulnerability Disclosure